title: Study into the role of cholecystokinin in bombesin-stimulated pancreatic growth in rats and hamsters.
abstract: The effects of cholecystokinin and bombesin on growth of the exocrine pancreas have been studied extensively in rats but not in hamsters. Since hamsters are frequently used for studying pancreatic carcinogenesis it seems highly relevant to determine the effects of these peptides on growth of the hamster pancreas as well. In order to determine whether or not bombesin stimulates pancreatic growth in hamsters and to investigate the role of cholecystokinin in mediating this effect, we conducted a 2-week experiment in which cholecystokinin and bombesin were administered to both rats and hamsters, either with or without lorglumide (CR-1409; a specific cholecystokinin receptor antagonist). Rats were included in the study for comparison. Cholecystokinin and bombesin were found to stimulate pancreatic growth and DNA synthesis in both species. Lorglumide did not significantly influence the effect of bombesin on pancreatic weight but did significantly inhibit DNA synthesis in both species. The effect of cholecystokinin on pancreatic weight was greater in hamsters than in rats. This effect was significantly inhibited by lorglumide in hamsters but not in rats, whereas a significant decrease in DNA content was attained in both species. Thus, this study shows marked differences between rats and hamsters in the pancreatic growth response to cholecystokinin and bombesin.
authors.affiliation: Department of Gastroenterology and Hepatology, University Hospital, Leiden, The Netherlands.
authors.forename: B R
authors.initials: BR
authors.lastname: Douglas
authors.forename: R A
authors.initials: RA
authors.lastname: Woutersen
authors.forename: J B
authors.initials: JB
authors.lastname: Jansen
authors.forename: L C
authors.initials: LC
authors.lastname: Rovati
authors.forename: C B
authors.initials: CB
authors.lastname: Lamers
mesh_terms: D000818:Animals; D001835:Body Weight / Q000187:drug effects; D001839:Bombesin / Q000494:pharmacology*; D002766:Cholecystokinin / Q000502:physiology*; D006224:Cricetinae; D004247:DNA / Q000378:metabolism; D008297:Male; D008647:Mesocricetus; D010179:Pancreas / Q000187:drug effects / Q000254:growth & development*; D011377:Proglumide / Q000031:analogs & derivatives / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013045:Species Specificity; D013997:Time Factors
chemical_list: D011506:Proteins; D004247:DNA; D002766:Cholecystokinin; D011377:Proglumide; C048181:lorglumide; D001839:Bombesin